Literature DB >> 22017238

DNA-repair gene variants are associated with glioblastoma survival.

Carl Wibom1, Sara Sjöström, Roger Henriksson, Thomas Brännström, Helle Broholm, Patrik Rydén, Christoffer Johansen, Helle Collatz-Laier, Sara Hepworth, Patricia A McKinney, Lara Bethke, Richard S Houlston, Ulrika Andersson, Beatrice S Melin.   

Abstract

Patient outcome from glioma may be influenced by germline variation. Considering the importance of DNA repair in cancer biology as well as in response to treatment, we studied the relationship between 1458 SNPs, which captured the majority of the common genetic variation in 136 DNA repair genes, in 138 glioblastoma samples from Sweden and Denmark. We confirmed our findings in an independent cohort of 121 glioblastoma patients from the UK. Our analysis revealed nine SNPs annotating MSH2, RAD51L1 and RECQL4 that were significantly (p < 0.05) associated with glioblastoma survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017238     DOI: 10.3109/0284186X.2011.616284

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  8 in total

1.  Intronic and promoter polymorphisms of hMLH1/hMSH2 and colorectal cancer risk in Heilongjiang Province of China.

Authors:  Guangxiao Li; Fulan Hu; Fengshun Yuan; Jialong Fan; Zhifu Yu; Zhiwei Wu; Xiaojuan Zhao; Ye Li; Shuying Li; Jiesheng Rong; Binbin Cui; Xinshu Dong; Huiping Yuan; Yashuang Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-06       Impact factor: 4.553

2.  Single-Nucleotide Polymorphisms of the MSH2 and MLH1 Genes, Potential Molecular Markers for Susceptibility to the Development of Basal Cell Carcinoma in the Brazilian Population.

Authors:  Poliane da Silva Calixto; Otávio Sérgio Lopes; Mayara Dos Santos Maia; Sylvia Satomi Takeno Herrero; Carlos Alberto Longui; Cynthia Germoglio Farias Melo; Ivan Rodrigues de Carvalho Filho; Leonardo Ferreira Soares; Arnaldo Correia de Medeiros; Plínio Delatorre; André Salim Khayat; Rommel Rodriguez Burbano; Eleonidas Moura Lima
Journal:  Pathol Oncol Res       Date:  2017-06-30       Impact factor: 3.201

3.  The prognostic significance of polymorphisms in hMLH1/hMSH2 for colorectal cancer.

Authors:  Yibaina Wang; Guangxiao Li; Fulan Hu; Haoran Bi; Zhiwei Wu; Xiaojuan Zhao; Ye Li; Shuying Li; Dandan Li; Binbin Cui; Xinshu Dong; Yashuang Zhao
Journal:  Med Oncol       Date:  2014-05-04       Impact factor: 3.064

4.  Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growth.

Authors:  Yan-Xia Zhang; Zhen Yue; Ping-Yu Wang; You-Jie Li; Jia-Xuan Xin; Min Pang; Qing-Yin Zheng; Shu-Yang Xie
Journal:  Biomed Pharmacother       Date:  2012-12-28       Impact factor: 6.529

Review 5.  DNA repair mechanisms and Toxoplasma gondii infection.

Authors:  Beata Smolarz; Jan Wilczyński; Dorota Nowakowska
Journal:  Arch Microbiol       Date:  2013-12-14       Impact factor: 2.552

6.  Genetic links between post-reproductive lifespan and family size in Framingham.

Authors:  Xiaofei Wang; Sean G Byars; Stephen C Stearns
Journal:  Evol Med Public Health       Date:  2013-06-25

7.  Overexpression of RAD51B predicts a preferable prognosis for non-small cell lung cancer patients.

Authors:  Mengyin Wu; Zufeng Sheng; Lingyan Jiang; Zhengyuan Liu; Yuhua Bi; Yueping Shen
Journal:  Oncotarget       Date:  2017-09-06

8.  DNA repair gene XRCC4 codon 247 polymorphism modified diffusely infiltrating astrocytoma risk and prognosis.

Authors:  Zhong-Hui Lin; Jin-Chun Chen; Yun-Sun Wang; Teng-Jiao Huang; Jin Wang; Xi-Dai Long
Journal:  Int J Mol Sci       Date:  2013-12-27       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.